Application of bacteroides fragilis YCH46 in preparation of drugs for treatment or adjuvant treatment of hypertension
A Bacteroides fragilis, adjuvant therapy technology, applied in the field of medicine, can solve problems such as unreported, and achieve the effects of easy acceptance, low compliance rate and compliance, and mature amplification technology
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Example 1: Changes in the intestinal flora of rats in the HSD group
[0047] The feces samples of the rats in the control group and the HSD group were collected, and the total DNA in the feces was extracted by using the improved CTAB method. Universal primers were used to build the library. After the library was built, MiSeq (Illumina) was used for sequencing, and the data obtained by the sequencing was analyzed using QIIME2 software. The correlation analysis results between intestinal microbial genus and systolic blood pressure and diastolic blood pressure figure 1 As shown, the results showed that Bacteroides were closely related to systolic blood pressure (SBP) and diastolic blood pressure (DBP).
[0048] Among them, the general primers of the 16s rRNA gene used for library construction are:
[0049] Upstream primers:
[0050] 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3',
[0051] Downstream primers:
[0052] 5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTAC...
Embodiment 2
[0054] Example 2: Isolation and cultivation of Bacteroides fragilis (Bacteroides fragilis) YCH46 in human intestine
[0055] Take 1g of fresh feces from healthy people and add it to 9mL M2GSC liquid bacterial culture medium to mix well, then use M2GSC liquid bacterial culture medium to dilute 10 concentration gradients in a 10-fold gradient, and take 0.3mL each to spread on M2GSC solid bacteria containing 1.5% agar On the culture medium, cultured at 37° C. for 48 hours in an anaerobic environment, a single colony was taken for 16s rDNA sequencing, and Bacteroides fragilis (Bacteroides fragilis) YCH46 was isolated.
[0056] In addition, the content of Bacteroides fragilis YCH46 in the feces of control group and HSD group rats, hypertensive patients and healthy people was further verified by rtPCR technology, using TB Green Premix Ex Taq (Takara) reagent in CFX96 Real-Time PCR System (Bio -Rad) carry out rtPCR, and the detection result is as follows image 3 As shown, the resul...
Embodiment 3
[0057] Example 3: Effects of Bacteroides fragilis (Bacteroides fragilis) YCH46 on corticosterone synthesis in colon tissue cultured in vitro
[0058] Bacteroides fragilis (Bacteroides fragilis) YCH46 was amplified in M2GSC liquid bacterial culture medium at 37°C for 24 hours by anaerobic shaking to obtain Bacteroides fragilis YCH46 culture solution, which was centrifuged at 5000g for 5 minutes, and the supernatant of the culture solution was filtered out with a 0.2 μm filter B.f.S, the liquid was labeled as B.f.S; similarly, the M2GSC liquid bacterial medium was centrifuged at 5000g for 5 minutes, and the supernatant was filtered and sterilized with a 0.2 μm filter, and the liquid was labeled as M2GSC; under sterile conditions, the normal control group and high-salt induced The colonic tissue of C57BL / 6 male mice in the group, each colonic tissue was fully cut up and divided into two groups, cultured in a sterile 12-well plate, DMEM medium and fetal bovine serum were added to e...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com